NM_006031.6:c.931G>T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006031.6(PCNT):c.931G>T(p.Ala311Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,596,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A311T) has been classified as Uncertain significance.
Frequency
Consequence
NM_006031.6 missense
Scores
Clinical Significance
Conservation
Publications
- microcephalic osteodysplastic primordial dwarfism type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Moyamoya diseaseInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006031.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | NM_006031.6 | MANE Select | c.931G>T | p.Ala311Ser | missense | Exon 5 of 47 | NP_006022.3 | ||
| PCNT | NM_001315529.2 | c.577G>T | p.Ala193Ser | missense | Exon 5 of 47 | NP_001302458.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | ENST00000359568.10 | TSL:1 MANE Select | c.931G>T | p.Ala311Ser | missense | Exon 5 of 47 | ENSP00000352572.5 | ||
| PCNT | ENST00000480896.5 | TSL:1 | c.577G>T | p.Ala193Ser | missense | Exon 5 of 47 | ENSP00000511989.1 | ||
| PCNT | ENST00000695558.1 | c.931G>T | p.Ala311Ser | missense | Exon 5 of 48 | ENSP00000512015.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000184 AC: 4AN: 217816 AF XY: 0.00000852 show subpopulations
GnomAD4 exome AF: 0.0000208 AC: 30AN: 1444694Hom.: 0 Cov.: 34 AF XY: 0.0000223 AC XY: 16AN XY: 716836 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74392 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.931G>T (p.A311S) alteration is located in exon 5 (coding exon 5) of the PCNT gene. This alteration results from a G to T substitution at nucleotide position 931, causing the alanine (A) at amino acid position 311 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PCNT-related disorder Uncertain:1
The PCNT c.931G>T variant is predicted to result in the amino acid substitution p.Ala311Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0041% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at